This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a fluorophenyl sulfonyl group and an azetidine ring, makes it a valuable intermediate for designing molecules with potential biological activity. It is often explored in the development of enzyme inhibitors, targeting specific pathways involved in diseases such as inflammation, cancer, and central nervous system disorders. Additionally, its carboxylic acid group allows for further chemical modifications, enabling the creation of derivatives with optimized pharmacokinetic properties. Researchers also investigate its potential as a building block in medicinal chemistry for the development of small-molecule therapeutics.